Homepage
Aspen Announcement to JSE
Announcement regarding the acquisition of the pharmaceutical business of Sigma Pharmaceuticals Limited by Aspen.
Read MoreAspen make a bid for Sigma
Aspen shareholders are advised that Aspen has submitted an indicative non-binding proposal to acquire, either directly or through a wholly-owned subsidiary, Sigma Pharmaceuticals Limited.
Read MoreAspen and GSK Agree On Series Of Strategic Transactions
Aspen, Africa’s largest pharmaceutical manufacturer, has announced that it has agreed to multiple, strategic, inter-dependent transactions with a leading multinational pharmaceutical group, GlaxoSmithKline.
Read MoreDiversity and Flexibility eNews
Aspen’s high level of flexibility has shown demonstrable business outcomes in addition to the attraction/retention of diverse talent, including consistently meeting sales objectives and extremely high value customer relationships.
Read MoreAspen take on Tritace and Cardizem
Aspen Pharmacare have signed a licensing agreement with Sanofi-Aventis for the distribution, sales and marketing of Tritace and Cardizem.
Read MoreAspen form alliance with Actavis
Aspen Australia have signed a license agreement with Actavis, taking on the sales, marketing and distribution of two products, Neotigason and Rapilysin.
Read More